Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Doctor Peter A. Dysert II, chief of pathology from 1998 to the present.
In 1999, Doctor George Netto became director of the pathology residency.
2001 ViroMed acquisition ViroMed, one of the leading laboratories in molecular microbial testing using real-time PCR platforms, becomes a part of LabCorp.
BUMC core laboratory, 2001.
2002 LabCorp acquires Dynacare With the acquisition of Dynacare, LabCorp expands its geographic presence in the western and midwestern United States, as well as creating LabCorp’s first significant international presence in Canada.
2003 DIANON Systems becomes part of LabCorp LabCorp continues to build the most robust anatomic pathology capabilities in the world by acquiring DIANON Systems, now Dianon Pathology.
2005 LabCorp acquires Esoterix, Inc. and US LABS Both Esoterix, Inc. and US LABS become part of the LabCorp family.
2006 Litholink becomes part of LabCorp LabCorp acquires Litholink, a leading provider of testing that provides targeted treatment information, helping physicians better manage and prevent chronic diseases, including kidney stones and chronic kidney disease.
2008 Tandem Laboratories purchased by LabCorp LabCorp expands its clinical trials, personalized medicine, and companion diagnostic capabilities by purchasing Tandem Laboratories.
2009 Monogram Biosciences is purchased by LabCorp LabCorp purchases Monogram Biosciences, a recognized leader in the discovery and commercialization of products to guide and improve the treatment of HIV, cancer, and other serious diseases.
2010 LabCorp finalizes acquisition of Genzyme Genetics LabCorp completes its $1 billion acquisition of Genzyme Genetics, a business unit of Genzyme Corporation.
2012 is a big year for the LabCorp brand.
2014 Two new additions to LabCorp LabCorp acquires LipoScience, Inc., a provider of specialized cardiovascular diagnostic lab tests based on nuclear magnetic resonance (NMR) technology.
2016 LabCorp acquires Sequenom LabCorp successfully completes the acquisition of Sequenom, a leader in non invasive prenatal testing (NIPT), women’s health and reproductive testing, and other services.
2019 LabCorp acquires MNG Laboratories On March 1, 2019, LabCorp acquires MNG Laboratories, an internationally recognized clinical diagnostic leader that specializes in next generation sequencing (NGS) and complex biochemical testing for neurology.
Rate how well Clinical Laboratory Partners lives up to its initial vision.
Do you work at Clinical Laboratory Partners?
Is Clinical Laboratory Partners' vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Clinical Pathology Laboratories | 1948 | $240.0M | 1,243 | 1 |
| Sonora Quest Labs | 1997 | $170.0M | 1,040 | 95 |
| Solstas Lab Partners Group, LLC | 1997 | $270.0M | 3,000 | - |
| BioReference Laboratories | 1981 | - | 5,000 | - |
| Oklahoma Blood Institute | 1977 | $100.0M | 680 | 23 |
| American Health Associates, Inc. | 1990 | $6.5M | 50 | 91 |
| Community Blood Center | 1995 | $50.0M | 64 | 15 |
| Biomat Usa, Inc. | 1986 | $250.0M | 750 | 90 |
| Interstate Blood Bank | 1949 | $170.0M | 1,250 | 7 |
| Schryver Medical | 1993 | $130.0M | 200 | - |
Zippia gives an in-depth look into the details of Clinical Laboratory Partners, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Clinical Laboratory Partners. The employee data is based on information from people who have self-reported their past or current employments at Clinical Laboratory Partners. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Clinical Laboratory Partners. The data presented on this page does not represent the view of Clinical Laboratory Partners and its employees or that of Zippia.
Clinical Laboratory Partners may also be known as or be related to CLINICAL LABORATORY PARTNERS, Clinical Laboratory Partners, Clinical Laboratory Partners LLC and Clinical Laboratory Partners, LLC.